Angioscore, Inc. v. Trireme Medical, Inc.

Good Law
50 F. Supp. 3d 1276·2014 WL 2891675·2014 U.S. Dist. LEXIS 87265
United States District Court, Northern District of CaliforniaJune 25, 2014Case No.: 12-CV-3393 YGRCalifornia12,829 words

Opinion

Lead Opinion

Rogers, J.

Ordek ConstruiNG Claims in Dispute; Granting in Part and Denying in Part Defendants’ Motion for Summary Judgment of Non-Infringement

INTRODUCTION

At the heart of this patent action is an angioplasty device named “Chocolate.” *1280 Defendant Eitan Konstantino, an inventor of angioplasty devices, worked for plaintiff AngioScore, Inc. (“AngioScore”), a company that makes and sells angioplasty devices. Later, he started his own company, TriReme Medical, Inc., which has since reorganized as defendant TriReme Medical, LLC (“TriReme”). TriReme makes and sells the Chocolate device. AngioS-core’s operative Supplemental and Second Amended Complaint alleges that Chocolate infringes United States Patent No. 7,691,119, which AngioScore owns by assignment. (Dkt. No. 118 ¶¶ 14, 19; id., Ex. A (“ '119 Patent”).) AngioScore brings a single claim of patent infringement against TriReme, Konstantino, and two corporate entities associated with TriReme, namely, Quattro Vascular Pte Ltd. (“Quattro”), and QT Vascular Ltd. (f/k/a QT Vascular Pte. Ltd.) (“QTV”). 1 Defendants answered, asserting counterclaims for (1) a declaration of noninfringement of the '119 Patent, (2) a declaration of invalidity of…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.